DR. ROSLYN RIVKAH ISSEROFF, M.D.
Dermatology at C St, Sacramento, CA
License number
California G43459
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
3301 C St SUITE 1400, Sacramento, CA 95816
Phone
(916) 734-6795
(916) 442-5702 (Fax)
(916) 734-6793 (Fax)
(916) 442-5702 (Fax)
(916) 734-6793 (Fax)
Personal information
See more information about ROSLYN RIVKAH ISSEROFF at radaris.comName
Address
Phone
3200 Barberry Ln, Sacramento, CA 95864
Professional information
Roslyn Rivkah Isseroff, Sacramento CA
Specialties:
Dermatologist
Address:
3301 C St, Sacramento, CA 95816
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
New York University Langone Medical Center - Fellowship - Dermatologic Research
New York University Langone Medical Center - Fellowship - Dermatologic Research
Board certifications:
American Board of Dermatology Certification in Dermatology
Dr. Roslyn R Isseroff, Roseville CA - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Gregory M. Bricca, M.D., Inc
9269 Sierra College Blvd, Roseville 95661
(916) 772-1585 (Phone), (916) 772-5685 (Fax)
UC Davis Medical Group Dermtlgy
3301 C St SUITE 1300, Sacramento 95816
(916) 734-6111 (Phone)
9269 Sierra College Blvd, Roseville 95661
(916) 772-1585 (Phone), (916) 772-5685 (Fax)
UC Davis Medical Group Dermtlgy
3301 C St SUITE 1300, Sacramento 95816
(916) 734-6111 (Phone)
Certifications:
Dermatology, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1975
Colum Presby
Graduated: 1976
New York University Med Center
Graduated: 1979
New York University School Of Med
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1975
Colum Presby
Graduated: 1976
New York University Med Center
Graduated: 1979
New York University School Of Med
Vitro Assay System Using A Human Cell Line For Testing The Effectiveness Of Anti-Papilloma Viral Agents
US Patent:
6200745, Mar 13, 2001
Filed:
Nov 19, 1998
Appl. No.:
9/195817
Inventors:
John W. Kreider - Palmyra PA
Michael G. Angell - Hamburg MI
Loyd H. Smith - Davis CA
Margaret Hitchcock - Davis CA
Chris Foster - Carmichael CA
Roslyn Rivkah Isseroff - Sacramento CA
Michael G. Angell - Hamburg MI
Loyd H. Smith - Davis CA
Margaret Hitchcock - Davis CA
Chris Foster - Carmichael CA
Roslyn Rivkah Isseroff - Sacramento CA
Assignee:
The Penn State Research Foundation - University Park PA
The Regents of the University of California - Oakland CA
The Regents of the University of California - Oakland CA
International Classification:
C12Q 168, C12Q 170
US Classification:
435 5
Abstract:
An in vitro method for testing the effectiveness of antiviral agents is provided. The method allows for screening anti-papillomavirus drugs which can interfere with the early and maintenance stages of papillomavirus infection. The method comprises growing epithelial cells susceptible to infection with papillomavirus in a monolayer system and measuring the effectiveness of various agents present in the growing media to interfere with the growth of the virus. The method is free from interferences caused by the regional variability, since the cell cultures are evenly dispersed monolayers.
Corneal Epithelial Graft Composites
US Patent:
2002003, Apr 4, 2002
Filed:
Feb 28, 2001
Appl. No.:
09/796995
Inventors:
Roslyn Isseroff - Sacramento CA, US
Ivan Schwab - Fair Oaks CA, US
Ivan Schwab - Fair Oaks CA, US
International Classification:
A61K045/00, C12N005/08
US Classification:
435/366000, 424/093700
Abstract:
The present invention relates to a bioengineered composite graft for the treatment of a damaged or diseased corneal epithelial surface wherein the corneal epithelial composite graft comprises ex vivo corneal epithelial stem cells cultured on an extracellular carrier matrix, the methods of making and using the corneal epithelial composite graft.
Beta-2 Adrenergic Receptor Agonists And Antagonists And Modulation Of Wound Healing
US Patent:
2010021, Aug 26, 2010
Filed:
Apr 10, 2006
Appl. No.:
11/886363
Inventors:
Roslyn Rivkah Isseroff - Sacramento CA, US
Christine E. Pullar - Sacramento CA, US
Christine E. Pullar - Sacramento CA, US
International Classification:
A61K 31/5377, C07D 417/12, C07C 237/32, A61K 31/166, C07C 215/56, A61K 31/138, C07D 209/88, A61K 31/403, C07D 215/20, A61K 31/4704, C07C 215/64, C07C 311/32, A61K 31/18, C07C 215/60, A61K 31/137, A61K 9/00, A61P 17/02, A61P 27/02
US Classification:
424423, 544134, 5142362, 564165, 514620, 564428, 514652, 548444, 514411, 546158, 514312, 564443, 514650, 564 99, 514605, 514653
Abstract:
Methods for increasing rate of healing of wounds in epithelial tissues by administration of beta-2 adrenergic receptor antagonists to target patients are provided. Methods for decreasing cell growth around implanted devices and methods for decreasing wound contraction by administration of beta-2 adrenergic receptor agonists are also provided. Pharmaceutical compositions and kits including beta-2 adrenergic receptor agonists and antagonists are described, as are devices coated with beta-2 adrenergic receptor agonists.
Corneal Epithelial Graft Composites
US Patent:
2004013, Jul 15, 2004
Filed:
Dec 24, 2003
Appl. No.:
10/746505
Inventors:
Roslyn Isseroff - Sacramento CA, US
Ivan Schwab - Fair Oaks CA, US
Ivan Schwab - Fair Oaks CA, US
International Classification:
C12N005/08
US Classification:
435/368000
Abstract:
The present invention relates to a bioengineered composite graft for the treatment of a damaged or diseased corneal epithelial surface wherein the corneal epithelial composite graft comprises ex vivo corneal epithelial stem cells cultured on an extracellular carrier matrix, the methods of making and using the corneal epithelial composite graft.
Roslyn Isseroff
Location:
Sacramento, California Area